INS and obesity due to melanocortin 4 receptor deficiency: Given that BAT is highly associated with improved glucose tolerance and insulin sensitivity119, one could envision a personalized treatment developed for patients with cancer and obesity, whereby AMT is used not only to target cancer and its unique metabolism but also to treat the patients’ metabolic disease.